Patent US5084350A successfully refreshed from Google Patents.
US5084350A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for encapsulating biologically active material including cells
Assignee: Royal Institution for the Advancement of Learning
•
Filing: 1990-02-16
•
Granted: 1992-01-28
•
Expires: 2010-02-16
Abstract
Abstract Method for encapsulating biologically active material within a semipermeable capsule wherein gelled beads are obtained by suspending the material in a solution of a water-soluble substance which can be reversibly gelled, forming the solution into droplets and gelling the droplets to produce discrete shaped-retaining temporary gelled beads. The improvement comprises the subsequent steps of (a) suspending the gelled beads in a solution of a water-soluble substance which can be reversibly gelled (b) forming droplets from the suspension of (a), thereby obtaining droplets which contain one or more gelled beads of step (a); (c) gelling the droplets of step (b) to produce discrete shaped-retaining temporary gelled beads which contain the gelled beads of step (a); (d) forming semi-permeable membranes on each of the gelled beads of step (c), thereby preventing the incorporation of any biologically active material of step (a) into the membranes and (e) reliquifying the gel within the membranes, thereby dispersing the content of the gelled beads of step (a) within the capsule.
Inventors
- 👤 Thomas M. S. Chang
- 👤 Harry Wong
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 12:52
CPC Classifications
B; B01; B01J; B01J13/00; B01J13/02; B01J13/04; B01J13/046; C; C12; C12N; C12N11/00; C12N11/02; C12N11/04; C12N5/00; C12N5/0012; C12N5/06; C12N5/0602; C12N5/067; C12N5/0671; C12N2533/00; C12N2533/70; C12N2533/74; Y; Y10; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2984
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
160 words
In a method for encapsulating biologically active material within a semipermeable capsule wherein gelled beads are obtained by suspending said material in a solution of water-soluble substance which can be reversibly gelled, forming said solution into droplets, and gelling said droplets to produce discrete shape-retaining temporary gelled beads; the improvement comprising the steps of: a) suspending said gelled beads in a solution of a water-soluble substance which can be reversibly gelled; b) forming droplets which contain one or more of the gelled beads of step a); c) gelling said droplets of step b) to produce discrete shape-retaining temporary gelled beads which contain said gelled beads of step a); d) forming semi-permeable membranes on each gelled bead of step c), thereby preventing the incorporation of any biologically active material from said gelled beads of step a) into said membranes; and e) reliquifying the gel within said membranes, thereby dispersing the content of said gelled beads of step a) within said capsule.
Claim 2
Dependent Claim
160 words
In a method for encapsulating biologically active material within a semipermeable capsule wherein gelled beads are obtained by suspending said material in a solution of water-soluble substance which can be reversibly gelled, forming said solution into droplets, and gelling said droplets to produce discrete shape-retaining temporary gelled beads; the improvement comprising the steps of: a) suspending said gelled beads in a solution of a water-soluble substance which can be reversibly gelled; b) forming droplets which contain one or more of the gelled beads of step a); c) gelling said droplets of step b) to produce discrete shape-retaining temporary gelled beads which contain said gelled beads of step a); d) forming semi-permeable membranes on each gelled bead of step c), thereby preventing the incorporation of any biologically active material from said gelled beads of step a) into said membranes; and e) reliquifying the gel within said membranes, thereby dispersing the content of said gelled beads of step a) within said capsule.
Claim 3
Dependent Claim
18 words
The method according to claim 1, wherein said water-soluble substance which can be reversibly gelled is a gum.
Claim 4
Dependent Claim
74 words
The method according to claim 2, wherein said gum has free acid functional groups and said membrane formation step is effected by contacting the temporary capsules with a polymer of a molecular weight between 3,000 and 100,000 daltons and having free amino functional groups with cationic charge, said contacting being effective to form permanent crosslinks between said free amino groups of said polymer and acid functional groups in a surface layer of the capsule.
Claim 5
Dependent Claim
38 words
The method according to claim 3, wherein said polymer is selected from the group consisting of: polylysine, polyethylenimine, polyarginine, and polymer containing quaternary ammonium groups, said polymer having an average molecular weight of about 15,000 to 35,000 daltons.
Claim 6
Dependent Claim
22 words
The method according to claim 2, wherein said gum is selected from the group consisting of: alkali metal alginate, carrageenan and gelatin.
Claim 7
Dependent Claim
27 words
The method according to claim 5, wherein said alkali metal alginate is sodium alginate and said gelling of the droplets is effected by using a calcium solution.
Claim 8
Dependent Claim
40 words
The method according to claim 6, wherein reliquifying the gel is effected by removing the calcium ions contained within said gelled beads, thereby resolubilizing the gelled alginate interior of the membranes of said capsule including said gelled beads contained therein.
Claim 9
Dependent Claim
33 words
The method according to claim 1, wherein said gelling of the droplets is effected by using calcium ions, alkaline ions, lowering the temperature to below the gelling temperature, or by changing the pH.
Claim 10
Dependent Claim
32 words
The method according to claim 1, wherein said reliquifying of the gel is effected by using a chelating agent, increasing the temperature to above the gelling temperature, or by changing the pH.
Claim 11
Dependent Claim
28 words
The method according to claim 1, wherein said biologically active material is selected from the group consisting of: viable cells, viable tissues, proteins, immunoproteins, peptides, hormones and drugs.
Claim 12
Dependent Claim
27 words
The method according to claim 10, wherein said viable cells are selected from the group consisting of: liver cells, endocrine cells, pancreatic cells, erythrocytes, leucocytes and platelets.
Claim 13
Dependent Claim
29 words
The method according to claim 11, wherein said liver cells include hepatocytes and Kupffer cells, said endocrine cells include thyroid tissue cells and said pancreatic cells include islet cells.
Claim 14
Dependent Claim
21 words
The method according to claim 10, wherein said viable tissues selected from the group consisting of: endocrine tissues and liver tissues.
Claim 15
Dependent Claim
36 words
The method according to claim 1, wherein said gelled beads of step a) vary in diameter between 1μ and 1 mm and said gelled beads of step c) vary in diameter between 2μ and 10 mm.
Claim 16
Dependent Claim
24 words
A semipermeable capsule obtained according to the method of claim 1 wherein its membrane is devoid of any encapsulated material embedded or protruding therein.
Claim 17
Dependent Claim
84 words
A semipermeable capsule obtained according to the method of claim 1 suitable for implantation in a mammalian host and containing one or more viable, healthy physiologically active living tissue cells or other biologically active material, said capsule on implantation being impermeable to said host immune system proteins or immune system cells but permeable to tissue nutrients and to metabolites or secretions produced by said encapsulated tissue or biologically active material, thereby said capsules being devoid of aggregation and of immunological reactions of said host.
References Cited (Backward Citations)
US4352883A
Cited
US4789516A
Cited
US4663286A
Cited
US4744933A
Cited
US4956128A
Cited
US4833081A
Cited
US4927761A
Cited
US4942129A
Cited
US4923645A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-01-27 | 1995-07-29 | 1996-01-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-01-27 | 1999-07-29 | 2000-01-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-01-27 | 2003-07-29 | 2004-01-28 | $7700.00 | Window Closed / Lapsed |